---
title: "AXA Mansard Approves Up to ₦18.3B Rights Issue Plan"
description: "AXA Mansard shareholders approved a plan to raise up to ₦18.3 billion via a rights issue, with final size and price set by the board after approvals."
canonical_url: "https://liners.com/news/axa-mansard-18-3bn-rights-issue-approval"
markdown_url: "https://liners.com/news/axa-mansard-18-3bn-rights-issue-approval.md"
type: "article"
language: "en"
published_at: "2026-10-11T11:08:16.401Z"
updated_at: "2026-10-11T11:08:18.166Z"
---

# AXA Mansard Approves Up to ₦18.3B Rights Issue Plan

AXA Mansard shareholders approved a plan to raise up to ₦18.3 billion via a rights issue, with final size and price set by the board after approvals.

## Breadcrumbs

- [News](/news)
- [AXA Mansard Approves Up to ₦18.3B Rights Issue Plan](/news/axa-mansard-18-3bn-rights-issue-approval)

## Content

## In Short
AXA Mansard has approval to raise up to ₦18.3 billion through a rights issue, subject to regulatory approvals. The board will decide the final offer size, price, and timing.

## What Happened
At its October 9 annual general meeting, [AXA Mansard](/axa-mansard) received shareholder approval to raise additional capital of up to ₦18.3 billion.

The proposed raise is a rights issue, which means new shares are offered to existing shareholders first, usually in proportion to what they already own. Shareholders can choose to buy more shares to maintain their percentage ownership, or decline and accept dilution, which means their ownership share gets smaller.

The company said the capital raise is still subject to relevant regulatory approvals. The board has also been authorised to set the final size of the rights issue, how many new ordinary shares will be issued, and the price per share.

If some shareholders do not take up their rights within the offer window, the company may offer those shares to other shareholders who indicated interest, subject to regulatory requirements.

Beyond the capital plan, shareholders also approved several standard AGM resolutions. These include receiving the 2025 audited financial statements, re-electing three non-executive directors, and appointing Ernst and Young as external auditors. The meeting also fixed non-executive director remuneration for 2026, and elected shareholder representatives to the statutory audit committee.

## Why It Matters
Rights issues are a common way for listed companies to raise fresh capital without bringing in new investors first. For a financial services company, added capital can support solvency requirements, underwriting capacity, and growth plans, depending on how the funds are used.

For investors, the key details to watch will be the offer price, the ratio, and the timetable. These determine whether the issue is attractive and how much existing shareholders need to invest to avoid dilution.

Regulatory approvals and the board’s final decision on terms will determine when the rights issue actually happens, and how much of the ₦18.3 billion ceiling AXA Mansard chooses to use.

## Sources and products

- [doclib.ngxgroup.com](https://doclib.ngxgroup.com/Financial_NewsDocs/48061_AXA_MANSARD_INSURANCE_PLC-AXA_MANSARD_-_AGM_RESOLUTIONS_CORPORATE_ACTIONS_OCTOBER_2026.pdf)
- [AXA Mansard](/axa-mansard)

## Related pages

- [Funding & Acquisitions](/news)

## Access and citation

- [Canonical HTML page](https://liners.com/news/axa-mansard-18-3bn-rights-issue-approval)
- [Markdown route index](/sitemap.md)
- [Agent access guide](/llms.txt)